AARD vs NFLX · $284.4M cap vs P/E 25, rev $12.56B
Aardvark Therapeutics, Inc. Common Stock (AARD) versus Netflix Inc (NFLX) — a side-by-side from cached financials, not a winner call.
Aardvark Therapeutics, Inc. Common Stock (AARD) is a biotechnology company listed on US.
Netflix Inc (NFLX) is a entertainment company listed on NASDAQ.
Latest reported AARD revenue for 2025-12-31 was $0. Net income was -$57.6M. Revenue was down 100.0% from 2024-12-31 to 2025-12-31. AARD currently screens at market cap $284.4M.
Latest reported NFLX revenue for 2026-06-30 was $12.56B. Net income was $3.40B. Revenue was up 2.5% from 2026-03-31 to 2026-06-30. NFLX currently screens at market cap $324.06B and trailing P/E 24.8.
AARD currently screens at market cap $284.4M. NFLX currently screens at market cap $324.06B and trailing P/E 24.8.
Not investment advice. Open the AARD and NFLX stock pages for the full models.
Not investment advice.